November 22, 2016 - By Ruchi Gupta · 0 Comments
The stock of 22nd Century Group Incorporated (NYSEMKT:XXII) registered an increase of 3.13% in short interest. XXII’s total short interest was 2.38 million shares in November as published by FINRA. Its up 3.13% from 2.31 million shares, reported previously. With 470,600 shares average volume, it will take short sellers 5 days to cover their XXII’s short positions. The short interest to 22nd Century Group Incorporated’s float is 4.05%. The stock decreased 5.13% or $0.06 during the last trading session, hitting $1.11. 22nd Century Group Inc (NYSEMKT:XXII) has risen 24.58% since April 20, 2016 and is uptrending. It has outperformed by 20.02% the S&P500.
22nd Century Group, Inc. is a plant biotechnology company. The company has a market cap of $104.24 million. The Firm is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It currently has negative earnings.
Insitutional Activity: The institutional sentiment increased to 1.3 in Q2 2016. Its up 0.44, from 0.86 in 2016Q1. The ratio improved, as 6 funds sold all 22nd Century Group Inc shares owned while 8 reduced positions. 4 funds bought stakes while 8 increased positions. They now own 3.62 million shares or 0.20% more from 3.61 million shares in 2016Q1.
Charter Tru last reported 35,725 shares in the company. Group Incorporated One Trading Lp holds 0% or 25,248 shares in its portfolio. Asset Inc holds 79,700 shares or 0.01% of its portfolio. The New York-based Cowen Gp has invested 0% in 22nd Century Group Inc (NYSEMKT:XXII). Us National Bank & Trust De accumulated 0% or 2,000 shares. Bancorp Of America De reported 44,889 shares or 0% of all its holdings. Moreover, Courier Capital has 0% invested in 22nd Century Group Inc (NYSEMKT:XXII) for 28,390 shares. Wells Fargo & Mn owns 6,000 shares or 0% of their US portfolio. Vanguard Grp accumulated 0% or 1.38 million shares. Creative Planning has invested 0% of its portfolio in 22nd Century Group Inc (NYSEMKT:XXII). Susquehanna Intl Grp Llp accumulated 85,638 shares or 0% of the stock. Investors Advisory Svcs, a Massachusetts-based fund reported 27,250 shares. Commercial Bank Of Mellon reported 84,073 shares or 0% of all its holdings. Two Sigma Lc reported 15,824 shares or 0.01% of all its holdings. Qci Asset Mgmt Ny holds 100 shares or 0% of its portfolio.
22nd Century Group, Inc., incorporated on September 12, 2005, is a plant biotechnology company. The Firm is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Firm is engaged in a range of activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a prescription smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA), a part of the National Institutes of Health (NIH); international licensing of its technology, tobaccos and trademarks; international sale of its branded tobaccos; contract manufacturing of third-party branded tobacco products, and research and development in Canada of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC) for the legal hemp industry, and plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids for the legal medical marijuana markets.
Another recent and important 22nd Century Group Inc (NYSEMKT:XXII) news was published by Businesswire.com which published an article titled: “22nd Century Group Announces Closing of $11.4 Million Above-Market Registered …” on October 19, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Ruchi Gupta